Conference abstractPublished 8 Mar 2018
Small or large the non-coding RNAs maintain order in the genome world and therefore can be used for a therapeutic aim
European Bio Immun(G)en Medicine Association, France
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In mammalian cells, the vast majority of transcribed RNAs are noncoding. Many of them are processed to generate small RNAs, including microRNAs, the best-known class of small RNAs. Other transcripts, so- called long noncoding RNAs or lncRNAs, remain larger than 200 nucleotides in their mature form. Through their interaction with DNA, RNA, and proteins, ncRNAs affect all levels of gene regulation, including chromatin remodeling, transcription, pre-mRNA splicing, mRNA turnover, mRNA translation, and protein stability. Through this multi-leveled influence on protein expression patterns, these vast families of noncoding RNAs affect all aspects of cell metabolism, including cell division, senescence, differentiation, stress response, immune activation, and apoptosis. It has recently become apparent that it exists a mutual regulatory influence between microRNAs and lncRNAs. A number of studies over the past decade have also begun to uncover the interaction among mammalian lncRNAs and miRNAs. (1) LncRNAs are targeted by miRNAs to reduce lncRNA stability. (2) LncRNAs can also function as molecular decoys or sponges of microRNAs, reported in a few circular RNAs studies. In addition, (3) lncRNAs can also compete with miRNAs for binding to shared target mRNAs and (4) are precursors for the generation of miRNAs to silence target mRNAs. All these mechanisms will directly alter the cellular response in physiologic and pathologic processes, making them therapeutic targets of great interest. A nanobiotechnology-based method, called Bio Immune (G)en Medicine, has dared to take up the challenge and uses these interactions between non-coding RNAs to regulate gene expression in a large number of pathologies exhibiting significant deregulation at the immuno-genetic level. Some clinical examples, in particular in oncology, will illustrate the method and facilitate its understanding.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Gilbert Glady”